Steun ons werk
Decorative header background

Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways.

Onderzoeksgroep Van Someren
Publicatiejaar 2019
Gepubliceerd in Nature Genetics
Auteur(s) P.R. Jansen, K. Watanabe, S. Stringer, N. Skene, J. Bryois, A.R. Hammerschlag, C.A. De Leeuw, Jeroen S Benjamins, A.B. Munoz-Manchado, M. Nagel, J.E. Savage, H. Tiemeier, T. White, J.Y. Tung, D.A. Hinds, V. Vacic, X. Wang, P.F. Sullivan, S. Van der Sluis, T.J.C. Polderman, A.B. Smit, J. Hjerling-Leffler, Eus Van Someren, Danielle Posthuma

Insomnia is the second most prevalent mental disorder, with no sufficient treatment available. Despite substantial heritability, insight into the associated genes and neurobiological pathways remains limited. Here, we use a large genetic association sample (n = 1,331,010) to detect novel loci and gain insight into the pathways, tissue and cell types involved in insomnia complaints. We identify 202 loci implicating 956 genes through positional, expression quantitative trait loci, and chromatin mapping. The meta-analysis explained 2.6% of the variance. We show gene set enrichments for the axonal part of neurons, cortical and subcortical tissues, and specific cell types, including striatal, hypothalamic, and claustrum neurons. We found considerable genetic correlations with psychiatric traits and sleep duration, and modest correlations with other sleep-related traits. Mendelian randomization identified the causal effects of insomnia on depression, diabetes, and cardiovascular disease, and the protective effects of educational attainment and intracranial volume. Our findings highlight key brain areas and cell types implicated in insomnia, and provide new treatment targets.

Steun ons werk

De Stichting Vrienden van het Herseninstituut ondersteunt baanbrekend hersenonderzoek. U kunt ons daarbij helpen.

Steun ons werk